30-Jan-2026
The Week That Was, The Week Ahead: Macro and Markets, Feb. 1
TipRanks (Sun, 1-Feb 4:15 AM ET)
Catalyst Watch: Amazon earnings, IPO blitz, gold swings, and the jobs report
Seeking Alpha News (Fri, 30-Jan 3:00 PM ET)
PRNewswire (Thu, 29-Jan 8:30 AM ET)
PRNewswire (Wed, 28-Jan 12:04 PM ET)
Elevance Health is the latest health insurer to face 2026 revenue decline
Seeking Alpha News (Wed, 28-Jan 6:39 AM ET)
Market Voices: Medicare Advantage, UPS layoffs, EU vs. Starlink
Seeking Alpha News (Tue, 27-Jan 2:59 PM ET)
Healthcare lobbying efforts reach record high in Washington: report
Seeking Alpha News (Tue, 27-Jan 2:21 PM ET)
Analysts Conflicted on These Healthcare Names: Centene (CNC) and AbbVie (ABBV)
TipRanks (Tue, 27-Jan 12:20 PM ET)
Centene (CNC) Receives a Buy from Bernstein
TipRanks (Tue, 27-Jan 7:45 AM ET)
Medicare Shock Sends UnitedHealth, Humana And CVS Tumbling
Benzinga (Tue, 27-Jan 7:17 AM ET)
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.
Centene trades on the NYSE stock market under the symbol CNC.
As of January 30, 2026, CNC stock price declined to $43.32 with 4,349,566 million shares trading.
CNC has a beta of 0.01, meaning it tends to be less sensitive to market movements. CNC has a correlation of 0.00 to the broad based SPY ETF.
CNC has a market cap of $21.28 billion. This is considered a Large Cap stock.
Last quarter Centene reported $50 billion in Revenue and $.50 earnings per share. This beat revenue expectation by $2 billion and exceeded earnings estimates by $.68.
In the last 3 years, CNC traded as high as $81.42 and as low as $25.08.
The top ETF exchange traded funds that CNC belongs to (by Net Assets): VTI, VOO, IVV, SPY, VB.
CNC has underperformed the market in the last year with a price return of -33.0% while the SPY ETF gained +15.6%. However, in the short term, CNC had mixed performance relative to the market. It has outperformed in the last 3 months, returning +23.7% vs +2.1% return in SPY. But in the last 2 weeks, CNC shares have been beat by the market, returning -5.3% compared to an SPY return of 0.0%.
CNC support price is $42.41 and resistance is $44.79 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CNC shares will trade within this expected range on the day.